标题
Critical analysis of antibacterial agents in clinical development
作者
关键词
-
出版物
NATURE REVIEWS MICROBIOLOGY
Volume 18, Issue 5, Pages 286-298
出版商
Springer Science and Business Media LLC
发表日期
2020-03-09
DOI
10.1038/s41579-020-0340-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Epidemiology of β-Lactamase-Producing Pathogens
- (2020) Karen Bush et al. CLINICAL MICROBIOLOGY REVIEWS
- Risk Factors for Development of Carbapenem Resistance Among Gram-Negative Rods
- (2019) Stefan E Richter et al. Open Forum Infectious Diseases
- Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent
- (2019) Melissa D. Barnes et al. mBio
- Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multi-Drug Resistant Gram-Negative Infections
- (2019) Laura McEntee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans
- (2019) Tao He et al. Nature Microbiology
- Non-traditional Antibacterial Therapeutic Options and Challenges
- (2019) Ursula Theuretzbacher et al. Cell Host & Microbe
- Will morphing boron-based inhibitors beat the β-lactamases?
- (2019) Alen Krajnc et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Activity of cefepime/zidebactam (WCK 5222) against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii endemic to New York City medical centres
- (2019) Zeb Khan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Designing development programs for non-traditional antibacterial agents
- (2019) John H. Rex et al. Nature Communications
- Frequency Distribution, Genotypes and the most Prevalent Sequence Types of New Delhi Metallo-beta-lactamase-Producing Escherichia coli among Clinical Isolates around the World; A Review
- (2019) Masoud Dadashi et al. Journal of Global Antimicrobial Resistance
- Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
- (2019) Sophia David et al. Nature Microbiology
- Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli
- (2019) Jian Sun et al. Nature Microbiology
- Phenotypic, biochemical and genetic analysis of KPC-41, a KPC-3 variant conferring resistance to ceftazidime-avibactam and exhibiting reduced carbapenemase activity
- (2019) Linda Mueller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- AcrAB-TolC efflux pump system plays a role in carbapenem non-susceptibility in Escherichia coli
- (2019) Shiela Chetri et al. BMC MICROBIOLOGY
- Emergence of NDM-producing Klebsiella pneumoniae and Escherichia coli in Spain: phylogeny, resistome, virulence and plasmids encoding blaNDM-like genes as determined by WGS
- (2019) María Pérez-Vázquez et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases
- (2019) Alen Krajnc et al. JOURNAL OF MEDICINAL CHEMISTRY
- Siderophore–Antibiotic Conjugate Design: New Drugs for Bad Bugs?
- (2019) Negash et al. MOLECULES
- Design of Next Generation Polymyxins with Lower Toxicity: The Discovery of SPR206
- (2019) Pamela Brown et al. ACS Infectious Diseases
- In vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin Against Multidrug Resistant Aerobic Gram-Negative Bacilli
- (2019) Wim A. Fleischmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Meropenem-Vaborbactam Activity against Carbapenem-Resistant Enterobacterales Isolates Collected in U.S. Hospitals During 2016-2018
- (2019) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pathogen-focused Clinical Development to Address Unmet Medical Need: Cefiderocol Targeting Carbapenem Resistance
- (2019) Roger Echols et al. CLINICAL INFECTIOUS DISEASES
- An Emerging Clone, KPC-2-Producing Klebsiella pneumoniae ST16, Associated with High Mortality Rates in a CC258 Endemic Setting
- (2019) Diego O Andrey et al. CLINICAL INFECTIOUS DISEASES
- LB7. A Randomized, Blinded, Placebo- and Vancomycin-Controlled, First-In-Human (FIH) Study of the Safety, Pharmacokinetics (PK), and Fecal Microbiome Effects of ACX-362E, a Novel Anti-Clostridial DNA Polymerase IIIC (polIIIC) Inhibitor
- (2019) Kevin W Garey et al. Open Forum Infectious Diseases
- 691. Activity of TNP-2092 Against Biofilms Formed by Prosthetic Joint Infection-Associated Staphylococci
- (2019) Cody Fisher et al. Open Forum Infectious Diseases
- 677. Activity of Novel β-Lactamase Inhibitor QPX7728 Combined with β-Lactam Agents When Tested Against Carbapenem-Resistant Enterobacteriaceae (CRE) Isolates
- (2019) Mariana Castanheira et al. Open Forum Infectious Diseases
- 697. Evaluation of Contezolid Activity to Anaerobic and Gram-positive-cocci Isolates from a Phase 3 Acute Bacterial Skin and Skin Structure Infection Clinical Trial (MRX-I-06)
- (2019) Yang Yang et al. Open Forum Infectious Diseases
- Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections
- (2019) Bin Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation
- (2018) Stephanie N Taylor et al. CLINICAL INFECTIOUS DISEASES
- Activity of omadacycline tested against Enterobacteriaceae causing urinary tract infections from a global surveillance program (2014)
- (2018) M.A. Pfaller et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals
- (2018) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme
- (2018) James A Karlowsky et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment
- (2018) Paolo Gaibani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OUP accepted manuscript
- (2018) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Effect of Porins and blaKPC Expression on Activity of Imipenem with Relebactam in Klebsiella pneumoniae: Can Antibiotic Combinations Overcome Resistance?
- (2018) Gregory Balabanian et al. Microbial Drug Resistance
- In Vitro Activity of LYS228, a Novel Monobactam Antibiotic, against Multidrug-Resistant Enterobacteriaceae
- (2018) Johanne Blais et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Past and Present Perspectives on β-Lactamases
- (2018) Karen Bush ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The present state of the tuberculosis drug development pipeline
- (2018) M Daben J Libardo et al. CURRENT OPINION IN PHARMACOLOGY
- β-lactam/β-lactamase inhibitor combinations: an update
- (2018) Kamaleddin H. M. E. Tehrani et al. MedChemComm
- Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities
- (2018) Muhammad Asif et al. Infection and Drug Resistance
- In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli
- (2018) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases
- (2018) Michael R. Jacobs et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015
- (2018) James A. Karlowsky et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)
- (2018) Krystyna M. Kazmierczak et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of nacubactam (RG6080/OP0595) combinations against MBL-producing Enterobacteriaceae
- (2018) Shazad Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii
- (2018) Mario Juhas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Analysis of the clinical antibacterial and antituberculosis pipeline
- (2018) Ursula Theuretzbacher et al. LANCET INFECTIOUS DISEASES
- Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design
- (2018) Pasquale Linciano et al. ACS Infectious Diseases
- 1359. Activity of Meropenem/Nacubactam Combination Against Gram-Negative Clinical Isolates: ROSCO Global Surveillance 2017
- (2018) Rusudan Okujava et al. Open Forum Infectious Diseases
- 1371. Safety, Tolerability, and Pharmacokinetics of Multiple Doses of TP-6076, a Novel, Fully Synthetic Tetracycline, in a Phase 1 Study
- (2018) Larry Tsai et al. Open Forum Infectious Diseases
- Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern Vietnam
- (2017) Nguyen Tuan Anh et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study
- (2017) Hajo Grundmann et al. LANCET INFECTIOUS DISEASES
- Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes
- (2017) Jooyoung Park et al. Nature Chemical Biology
- Multiple Ascending Dose Safety, Tolerability, and Pharmacokinetics of KBP-7072, a Novel Third-generation Tetracycline
- (2017) Fred Yang et al. Open Forum Infectious Diseases
- Combining the FtsZ-Targeting Prodrug TXA709 and the Cephalosporin Cefdinir Confers Synergy and Reduces the Frequency of Resistance in Methicillin-Resistant Staphylococcus aureus
- (2016) Malvika Kaul et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline
- (2016) Yunliang Zhang et al. JOURNAL OF ANTIBIOTICS
- Tetracycline Antibiotics and Resistance
- (2016) Trudy H. Grossman Cold Spring Harbor Perspectives in Medicine
- Eravacycline Is Active Against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii Isolates in the FDA-CDC Antimicrobial Resistance Isolate Bank Panels
- (2016) Corey Fyfe et al. Open Forum Infectious Diseases
- TXA709, an FtsZ-Targeting Benzamide Prodrug with Improved Pharmacokinetics and EnhancedIn VivoEfficacy against Methicillin-Resistant Staphylococcus aureus
- (2015) Malvika Kaul et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases
- (2015) David M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization ofEscherichia coliNDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3
- (2015) Richard A. Alm et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The metabolism and disposition of GSK2140944 in healthy human subjects
- (2015) Kitaw Negash et al. XENOBIOTICA
- Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases
- (2015) Gregory S. Basarab et al. Scientific Reports
- Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries
- (2014) M. Castanheira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
- (2014) Jason A Roberts et al. LANCET INFECTIOUS DISEASES
- New Insights into Dissemination and Variation of the Health Care-Associated Pathogen Acinetobacter baumannii from Genomic Analysis
- (2014) M. S. Wright et al. mBio
- Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them
- (2014) Leonard Amaral et al. Frontiers in Pharmacology
- A New-Class Antibacterial—Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
- (2014) Gregory S. Bisacchi et al. ACS Infectious Diseases
- Genomics of KPC-Producing Klebsiella pneumoniae Sequence Type 512 Clone Highlights the Role of RamR and Ribosomal S10 Protein Mutations in Conferring Tigecycline Resistance
- (2013) Laura Villa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance to AFN-1252 Arises from Missense Mutations inStaphylococcus aureusEnoyl-acyl Carrier Protein Reductase (FabI)
- (2013) Jiangwei Yao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
- (2012) A. Capone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Staphylococcus aureus FabI: Inhibition, Substrate Recognition, and Potential Implications for In Vivo Essentiality
- (2012) Johannes Schiebel et al. STRUCTURE
- Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study
- (2011) Gabriel Cabot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The MUT056399 Inhibitor of FabI Is a New Antistaphylococcal Compound
- (2011) S. Escaich et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The tetracycline resistome
- (2009) Maulik Thaker et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Inhibition of Methionyl-tRNA Synthetase by REP8839 and Effects of Resistance Mutations on Enzyme Activity
- (2008) L. S. Green et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now